ALNY · Categories · Coverage
ALNY - Analyst coverage initiated
Alnylam Pharmaceuticals Inc. (ALNY) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for ALNY
- BMO Capital Markets initiated coverage on Alnylam Pharma with a new price targetBMO Capital Markets initiated coverage of Alnylam Pharma with a rating of Outperform and set a new price target of $318.00
- Citigroup initiated coverage on Alnylam Pharma with a new price targetCitigroup initiated coverage of Alnylam Pharma with a rating of Buy and set a new price target of $380.00
- Truist initiated coverage on Alnylam Pharma with a new price targetTruist initiated coverage of Alnylam Pharma with a rating of Buy and set a new price target of $385.00
- Redburn Atlantic initiated coverage on Alnylam Pharma with a new price targetRedburn Atlantic initiated coverage of Alnylam Pharma with a rating of Buy and set a new price target of $353.00
- Scotiabank initiated coverage on Alnylam PharmaScotiabank initiated coverage of Alnylam Pharma with a rating of Sector Outperform
- Wolfe Research initiated coverage on Alnylam PharmaWolfe Research initiated coverage of Alnylam Pharma with a rating of Peer Perform
- Wells Fargo initiated coverage on Alnylam Pharma with a new price targetWells Fargo initiated coverage of Alnylam Pharma with a rating of Equal Weight and set a new price target of $171.00
- Wells Fargo initiated coverage on Alnylam PharmaWells Fargo initiated coverage of Alnylam Pharma with a rating of Equal Weight
- Raymond James initiated coverage on Alnylam Pharma with a new price targetRaymond James initiated coverage of Alnylam Pharma with a rating of Outperform and set a new price target of $208.00
- SMBC Nikko initiated coverage on Alnylam Pharma with a new price targetSMBC Nikko initiated coverage of Alnylam Pharma with a rating of Neutral and set a new price target of $220.00
- Bernstein initiated coverage on Alnylam Pharma with a new price targetBernstein initiated coverage of Alnylam Pharma with a rating of Outperform and set a new price target of $243.00
- Canaccord Genuity initiated coverage on Alnylam Pharma with a new price targetCanaccord Genuity initiated coverage of Alnylam Pharma with a rating of Buy and set a new price target of $310.00
- Cantor Fitzgerald initiated coverage on Alnylam Pharma with a new price targetCantor Fitzgerald initiated coverage of Alnylam Pharma with a rating of Neutral and set a new price target of $175.00
- William Blair initiated coverage on Alnylam PharmaWilliam Blair initiated coverage of Alnylam Pharma with a rating of Outperform
- Citigroup initiated coverage on Alnylam Pharmaceuticals with a new price targetCitigroup initiated coverage of Alnylam Pharmaceuticals with a rating of Buy and set a new price target of $223.00